SPY316.18+2.40 0.76%
DIA260.72+1.68 0.65%
IXIC10,492.50+148.61 1.44%

HC Wainwright & Co. Maintains Buy on Interpace Biosciences, Lowers Price Target to $11

HC Wainwright & Co. maintains Interpace Biosciences (NASDAQ:IDXG) with a Buy and lowers the price target from $12 to $11.

Benzinga · -
HC Wainwright & Co. maintains Interpace Biosciences (NASDAQ: IDXG) with a Buy and lowers the price target from $12 to $11.